Safety and immunogenicity of a GP120-CD4 chimeric subunit vaccine: A phase 1A randomized controlled trial

Authors
Category Primary study
JournalOpen Forum Infect. Dis.
Year 2019
This article has no abstract
Epistemonikos ID: 8362474b306fd2ab8d55f276e3cfbf055677fba7
First added on: May 09, 2021